Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.

ConclusionsThere is a twofold increase of the risk for AMI for DOACs, in comparison with VKAs in AF therapy. In addition results suggest that in patients with AF, during aspirin monotherapy, incidence of AMI is higher than during the use of VKAs.

Source: British Journal of Clinical Pharmacology - March 23, 2017 Category: Drugs & Pharmacology Authors: Leo M. Stolk, Frank Vries, Chiel Ebbelaar, Anthonius Boer, Tom Schalekamp, Patrick Souverein, Arina Cate ‐Hoek, Andrea M. Burden Tags: PHARMACOEPIDEMIOLOGY Source Type: research